Downregulation of miR-335 exhibited an oncogenic effect via promoting KDM3A/YAP1 networks in clear cell renal cell carcinoma

Wenqiang Zhang,Ruiyu Liu,Lin Zhang,Chao Wang,Ziyan Dong,Jiasheng Feng,Mayao Luo,Yifan Zhang,Zhuofan Xu,Shidong Lv,Qiang Wei
DOI: https://doi.org/10.1038/s41417-021-00335-3
IF: 5.854
2021-04-23
Cancer Gene Therapy
Abstract:Abstract Clear cell renal cell carcinoma (ccRCC) is the most common type of renal cancer affecting many people worldwide. Although the 5-year survival rate is 65% in localized disease, after metastasis, the survival rate is <10%. Emerging evidence has shown that microRNAs (miRNAs) play a crucial regulatory role in the progression of ccRCC. Here, we show that miR-335, an anti-onco-miRNA, is downregulation in tumor tissue and inhibited ccRCC cell proliferation, invasion, and migration. Our studies further identify the H3K9me1/2 histone demethylase KDM3A as a new miR-335-regulated gene. We show that KDM3A is overexpressed in ccRCC, and its upregulation contributes to the carcinogenesis and metastasis of ccRCC. Moreover, with the overexpression of KDM3A, YAP1 was increased and identified as a direct downstream target of KDM3A. Enrichment of KDM3A demethylase on YAP1 promoter was confirmed by CHIP-qPCR and YAP1 was also found involved in the cell growth and metastasis inhibitory of miR-335. Together, our study establishes a new miR-335/KDM3A/YAP1 regulation axis, which provided new insight and potential targeting of the metastasized ccRCC.
oncology,genetics & heredity,medicine, research & experimental,biotechnology & applied microbiology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to clarify the role of miR - 335 in clear cell renal cell carcinoma (ccRCC) and its regulatory mechanism. Specifically, the researchers hope to reveal through this study how miR - 335 affects the tumor growth and metastasis ability of ccRCC by regulating the KDM3A/YAP1 network. This not only helps to deeply understand the pathogenesis of ccRCC, but also provides potential targets for the development of new treatment strategies. ### Research Background and Objectives - **Background**: Clear cell renal cell carcinoma (ccRCC) is the most common type of kidney cancer. Although the 5 - year survival rate of local lesions is 65%, once metastasis occurs, the 5 - year survival rate drops to less than 10%. MicroRNA (miRNA) plays an important regulatory role in the progression of ccRCC. - **Objectives**: This study aims to explore the expression changes of miR - 335 in ccRCC and its impact on tumor growth and metastasis, and further reveal the mechanism of action of its downstream target genes KDM3A and YAP1. ### Main Findings 1. **Down - regulation of miR - 335 expression**: - Through bioinformatics analysis, the researchers found that miR - 335 was significantly down - regulated in ccRCC tissues. - Further experiments showed that over - expression of miR - 335 could inhibit the proliferation, invasion and migration abilities of ccRCC cells. 2. **KDM3A as a downstream target gene of miR - 335**: - KDM3A is a histone demethylase and is over - expressed in ccRCC. - The experimental results showed that miR - 335 could down - regulate its expression by binding to the 3'UTR region of KDM3A. - The dual - luciferase reporter gene experiment further verified this regulatory relationship. 3. **KDM3A promotes the growth and metastasis of ccRCC**: - Knock - down of KDM3A significantly inhibited the proliferation, invasion and migration abilities of ccRCC cells. - Conversely, over - expression of KDM3A promoted these processes. 4. **KDM3A activates YAP1 expression through demethylation**: - KDM3A enhances the expression of YAP1 through demethylation. - YAP1 is an important transcriptional regulator and is involved in tumorigenesis in various cancers. - The experimental results showed that KDM3A up - regulated its expression by binding to the YAP1 promoter region. 5. **Regulatory role of the miR - 335/KDM3A/YAP1 axis**: - Through co - transfection experiments, the researchers found that miR - 335 inhibited the expression of YAP1 by inhibiting the expression of KDM3A, and ultimately inhibited the growth and metastasis of ccRCC. - This regulatory axis plays a key role in the pathogenesis of ccRCC. ### Conclusion This study established the miR - 335/KDM3A/YAP1 regulatory axis and revealed that miR - 335 inhibits the growth and metastasis of ccRCC by inhibiting the expression of KDM3A and then inhibiting the expression of YAP1. This finding not only deepens the understanding of the pathogenesis of ccRCC, but also provides potential targets for the development of new treatment strategies.